Imatinib-Induced Long-Term Remission In A Relapsed Rcsd1-Abl1-Positive Acute Lymphoblastic Leukemia

Thomas Perwein,Sabine Strehl,Margit Koenig,Herwig Lackner, Renate Panzer-Gruemayer,Georg Mann,Andishe Attarbaschi,Ernst-Christian Urban,Oskar A. Haas

HAEMATOLOGICA（2016）

引用 18|浏览26

暂无评分

摘要

The treatment of patients with BCR-ABL1 -positive chronic myeloid leukemia and acute lymphoblastic leukemia (ALL) with tyrosine kinase inhibitors (TKIs) has significantly improved their overall survival.[1][1]–[3][2] Several reports confirm that this type of treatment may be similarly effective

查看译文

关键词

acute lymphoblastic leukemia,RCSD1-ABL1-positive,relapse,long-term remission,imatinib

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要